Vendor review
Cellupep reviews
Cellupep reviews from 43 independent lab tests (Retatrutide, Tirzepatide and BPC-157): grade A, purity and fill accuracy. Is Cellupep legit? See what its vials showed.
What the lab tests show
43 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 14, 2026 | Retatrutide | 99.99 % | 9.84 mg of 10 mg (-2 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 20 mg | Fail | View | |
| Aug 9, 2026 | Tirzepatide | 20 mg | Fail | View | |
| Aug 3, 2026 | Tirzepatide | 99.9 % | 45.9 mg of 50 mg (-8 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 26 mg of 30 mg (-13 %) | Pass | View |
| Aug 2, 2026 | Tesamorelin | 99.6 % | 12.1 mg of 10 mg (21 %) | Pass | View |
| Jul 20, 2026 | Tirzepatide | 99.9 % | 74.8 mg of 60 mg (25 %) | Pass | View |
| Jul 20, 2026 | Tirzepatide | 60 mg | View | ||
| Jul 13, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 99 % | 9.59 mg of 10 mg (-4 %) | Pass | View |
| May 11, 2026 | Retatrutide | 99.9 % | 4.97 mg of 5 mg (-1 %) | Pass | View |
| May 11, 2026 | Retatrutide | 99.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
| Apr 28, 2026 | GHK-Cu | 99.9 % | 44.7 mg of 50 mg (-11 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.2 % | 10 mg of 10 mg (0 %) | Pass | View |
| Mar 25, 2026 | Retatrutide | 99.9 % | 8.4 mg of 10 mg (-16 %) | Pass | View |
| Mar 22, 2026 | Retatrutide | 99.9 % | 26.3 mg of 30 mg (-12 %) | Pass | View |
| Mar 19, 2026 | BPC-157 | 98.7 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 19, 2026 | TB-500 | 99.2 % | 12.8 mg of 10 mg (28 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 51.1 mg of 50 mg (2 %) | Pass | View |
| Mar 17, 2026 | TB-500 | 99.7 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Mar 17, 2026 | BPC-157 | 99.2 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.9 % | 51.8 mg of 50 mg (4 %) | Pass | View |
| Feb 22, 2026 | GHK-Cu | 99.9 % | 32.7 mg of 10 mg (227 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.9 % | 8.31 mg of 10 mg (-17 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.7 % | 49.1 mg of 50 mg (-2 %) | Pass | View |
| Feb 20, 2026 | Tesamorelin | 99.73 % | 8.5 mg of 10 mg (-15 %) | Pass | View |
| Feb 18, 2026 | Retatrutide | 99.9 % | 19.1 mg of 20 mg (-4 %) | Pass | View |
| Feb 18, 2026 | TB-500 | 99.7 % | 9.94 mg of 10 mg (-1 %) | Pass | View |
| Feb 18, 2026 | Tesamorelin | 99.08 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Feb 18, 2026 | BPC-157 | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Feb 18, 2026 | Retatrutide | 99.9 % | 36.7 mg of 30 mg (22 %) | Pass | View |
| Feb 18, 2026 | GHK-Cu | 99.9 % | 42.3 mg of 50 mg (-15 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.8 % | 21.3 mg of 20 mg (7 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.2 % | 38.7 mg of 30 mg (29 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.6 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Jan 7, 2026 | BPC-157 | 99 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Dec 17, 2025 | Retatrutide | 99.84 % | 20.7 mg of 20 mg (3 %) | Pass | View |
| Dec 13, 2025 | Tirzepatide | 99.6 % | 68.5 mg of 60 mg (14 %) | Pass | View |
| Nov 25, 2025 | Tesamorelin | 97.8 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Nov 17, 2025 | Tirzepatide | 99.66 % | 62.5 mg of 60 mg (4 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.73 % | 29.5 mg of 30 mg (-2 %) | Pass | View |
| Oct 23, 2025 | TB-500 | 89.9 % | 4.77 mg of 5 mg (-5 %) | Pass | View |
| Oct 23, 2025 | BPC-157 | 94.72 % | 4.62 mg of 5 mg (-8 %) | Pass | View |
What Cellupep sells
No current listings on record.
About Cellupep
Finnrick has tested 43 samples from Cellupep across 6 products.